The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
2.730
-0.050 (-1.80%)
At close: Mar 9, 2026, 4:00 PM EDT
2.740
+0.010 (0.37%)
After-hours: Mar 9, 2026, 7:40 PM EDT
The Oncology Institute Revenue
The Oncology Institute had revenue of $136.56M in the quarter ending September 30, 2025, with 36.70% growth. This brings the company's revenue in the last twelve months to $461.04M, up 21.67% year-over-year. In the year 2024, The Oncology Institute had annual revenue of $393.41M with 21.33% growth.
Revenue (ttm)
$461.04M
Revenue Growth
+21.67%
P/S Ratio
0.57
Revenue / Employee
$558,835
Employees
825
Market Cap
268.58M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Community Health Systems | 12.49B |
| agilon health | 5.93B |
| Auna S.A. | 1.24B |
| Enhabit | 1.06B |
| Cross Country Healthcare | 1.05B |
| Nutex Health | 875.26M |
| Sonida Senior Living | 327.01M |
| Strata Critical Medical | 197.14M |
TOI News
- 2 months ago - U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care - GlobeNewsWire
- 2 months ago - The Oncology Institute Announces Leadership Promotions - GlobeNewsWire
- 2 months ago - The Oncology Institute: Making Progress - Seeking Alpha
- 3 months ago - The Oncology Institute Announces Resignation of Board Member Gabe Ling - GlobeNewsWire
- 4 months ago - The Oncology Institute, Inc. (TOI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Ascertain and The Oncology Institute Co-Develop ‘Touchless' AI Automation for Oncology Administration - GlobeNewsWire
- 4 months ago - The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call - GlobeNewsWire
- 5 months ago - Topicus: Rising To The Topicus Of VMS Supremacy In Europe - Seeking Alpha